Pharmasset, Inc. (NASDAQ:VRUS.DL)

CAPS Rating: No stars

A clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections.

Recs

4
Player Avatar majakblue (< 20) Submitted: 1/19/2008 12:48:27 AM : Underperform Start Price: $14.58 VRUS.DL Score: -837.76

Ridiculous run-up. Typical pharma wannabe IPO. It probably will outperform initially as investors raise the price artificially high, and then tank as it becomes clear that the company will not be profitable for years to come if ever. It would be a good investment if you want to time the market. Get out now! Before it goes plop plop fizz fizz. Whoops, thats another drug company. As for me, I am a geneticist -biochemist who has worked for pharma start-ups, and I think it is safer to invest in the lottery.

Featured Broker Partners


Advertisement